These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D; Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673 [TBL] [Abstract][Full Text] [Related]
5. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885 [TBL] [Abstract][Full Text] [Related]
6. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study. Griffin L; Hammond C; Liu D; Rademaker AW; Kiley J Contraception; 2017 Jun; 95(6):564-570. PubMed ID: 28238839 [TBL] [Abstract][Full Text] [Related]
7. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study. Short M; Dallay D; Omokanye S; Stauch K; Inki P Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528 [TBL] [Abstract][Full Text] [Related]
8. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S; Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014 [TBL] [Abstract][Full Text] [Related]
9. Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception. Qasba NT; Stutsman JW; Weaver GE; Jones KE; Daggy JK; Wilkinson TA J Womens Health (Larchmt); 2020 Jun; 29(6):815-818. PubMed ID: 31990605 [No Abstract] [Full Text] [Related]
10. Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil. Laporte M; Marcelino AC; da Cunha Pereira P; Espejo-Arce X; Juliato CT; Bahamondes L Int J Gynaecol Obstet; 2024 Jul; 166(1):305-311. PubMed ID: 38328989 [TBL] [Abstract][Full Text] [Related]
11. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217 [TBL] [Abstract][Full Text] [Related]
12. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study. Schnabel P; Merki-Feld GS; Malvy A; Duijkers I; Mommers E; van den Heuvel MW Clin Drug Investig; 2012 Jun; 32(6):413-22. PubMed ID: 22540269 [TBL] [Abstract][Full Text] [Related]
13. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy. Lazorwitz A; Coleman-Minahan K; Teal SB; Guiahi M J Adolesc Health; 2018 Sep; 63(3):363-364. PubMed ID: 30076014 [TBL] [Abstract][Full Text] [Related]